Christopher P. Schnittker
Nessuna posizione attualmente
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Wayne William Mills | M | - | 15 anni | |
Jeffrey Rayport | M | 64 |
1075 First Global Associates LLC (Pennsylvania)
1075 First Global Associates LLC (Pennsylvania) Internet RetailRetail Trade 1075 First Global Associates LLC provides e-commerce solutions and marketing services. It offers solutions for its partners through integrated e-commerce platform, which is comprised of three components: core technology, supporting infrastructure, and partner services. The company was founded in 1986 and is headquartered in Wilkes Barre, PA. | 25 anni |
Mark S. Menell | M | 59 |
1075 First Global Associates LLC (Pennsylvania)
1075 First Global Associates LLC (Pennsylvania) Internet RetailRetail Trade 1075 First Global Associates LLC provides e-commerce solutions and marketing services. It offers solutions for its partners through integrated e-commerce platform, which is comprised of three components: core technology, supporting infrastructure, and partner services. The company was founded in 1986 and is headquartered in Wilkes Barre, PA. | 24 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Patrick T. Mooney | M | 55 | 6 anni | |
Harry G. Mitchell | M | 73 | 5 anni | |
Michael Zasloff | M | 78 |
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | 9 anni |
Mike M. Goldberg | M | 65 | 3 anni | |
Robert Francis Doman | M | 74 | - | |
David Walton | M | - | - | |
Shawn Singh | M | 61 | 4 anni | |
Michael Dougherty | M | 66 |
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | 2 anni |
Thomas H. Bishop | M | 67 | 2 anni | |
Shepard M. Goldberg | M | 69 | 3 anni | |
Marshall D. Deweese | M | - | - | |
Joseph Slattery | M | 59 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | 5 anni |
Wendy DiCicco | F | 56 | 1 anni | |
Leanne Kelly | F | 47 |
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | 7 anni |
Stephen Rocamboli | M | 52 | 6 anni | |
Arthur H. Miller | M | 70 |
1075 First Global Associates LLC (Pennsylvania)
1075 First Global Associates LLC (Pennsylvania) Internet RetailRetail Trade 1075 First Global Associates LLC provides e-commerce solutions and marketing services. It offers solutions for its partners through integrated e-commerce platform, which is comprised of three components: core technology, supporting infrastructure, and partner services. The company was founded in 1986 and is headquartered in Wilkes Barre, PA. | - |
Roy C. Levitt | M | 70 |
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | 5 anni |
David R. Pohl | M | 64 | 1 anni | |
Andrew Scott Lapkin | M | - |
Lafayette College
| 4 anni |
Steve Meade | M | - |
Lafayette College
| 4 anni |
Daniel Rogers | M | 54 |
Lafayette College
| 4 anni |
Paul Knollmeyer | M | - |
Pricewaterhouse LLP
| 5 anni |
Scott C. Light | M | - |
Pricewaterhouse LLP
| 3 anni |
Stephen P. Gibson | M | 58 |
Pricewaterhouse LLP
| 7 anni |
Alan Hoffman | M | - |
Lafayette College
| 4 anni |
Karen Ghaffari | F | - |
Pricewaterhouse LLP
| 4 anni |
Terence Bergé | M | 54 |
Pricewaterhouse LLP
| 7 anni |
Edward Anthony Jones | M | 54 |
Pricewaterhouse LLP
| 5 anni |
Sunil K. Bhatia | M | - |
Pricewaterhouse LLP
| 7 anni |
Thomas Roloff | M | - |
Lafayette College
| 4 anni |
Jeff Wood | M | 53 |
Pricewaterhouse LLP
| 4 anni |
Daniel Patrick Ries | M | - |
Lafayette College
| 4 anni |
George Kollitides | M | 54 |
Lafayette College
| 4 anni |
Joseph Berry | M | - |
Pricewaterhouse LLP
| 3 anni |
Stephanie McSwain | F | - |
Lafayette College
| 4 anni |
Cary Marc Klivan | M | - |
Pricewaterhouse LLP
| 4 anni |
Bernice Bell | F | 52 |
Pricewaterhouse LLP
| 4 anni |
Dennis Montz | M | - |
Pricewaterhouse LLP
| 2 anni |
Carrie Lee | F | - |
Lafayette College
| 4 anni |
Bob Doyle | M | - |
Pricewaterhouse LLP
| 4 anni |
Todd Greene | M | - |
Pricewaterhouse LLP
| 3 anni |
Karen McLoughlin | F | 59 |
Pricewaterhouse LLP
| 6 anni |
Robert Young | M | - |
Lafayette College
| 4 anni |
Kaaren Sagastume | F | - |
Lafayette College
| 4 anni |
Adam J. Klaber | M | - |
Pricewaterhouse LLP
| - |
Stephen Wagenbach | M | - |
Lafayette College
| 4 anni |
Randall Oser | M | 53 |
Lafayette College
| 4 anni |
Alison M. Horowitz | F | 51 |
Pricewaterhouse LLP
| 2 anni |
James Prosper Serjeant | M | - |
Pricewaterhouse LLP
| 4 anni |
Chuck Linn | M | - |
Pricewaterhouse LLP
| 15 anni |
Vivek Gambhir | M | 55 |
Lafayette College
| 4 anni |
Alan A. Seigerman | M | - |
Pricewaterhouse LLP
| 2 anni |
Brian Joel Shevitz | M | - |
Lafayette College
| 4 anni |
Peter Lowry | M | - |
Pricewaterhouse LLP
| 4 anni |
Dana C. Russell | M | 62 |
Pricewaterhouse LLP
| 3 anni |
Giovanni Palacardo | M | - |
Pricewaterhouse LLP
| 3 anni |
Bruce Caswell | M | 58 |
Pricewaterhouse LLP
| 5 anni |
Donald Rober Bessler | M | - |
Pricewaterhouse LLP
| 5 anni |
Dan Campbell | M | 69 |
Pricewaterhouse LLP
| 13 anni |
Catherine D'Amico | F | 68 |
Pricewaterhouse LLP
| 15 anni |
Joseph P. Joseph | M | - |
Pricewaterhouse LLP
| 5 anni |
L. Dale Crandall | M | 82 |
Pricewaterhouse LLP
| 32 anni |
William Schafer | M | 66 |
Pricewaterhouse LLP
| 9 anni |
Bernard F. Pliska | M | 62 |
Pricewaterhouse LLP
| 11 anni |
Richard Liem | M | 70 |
Pricewaterhouse LLP
| 11 anni |
Walter T. Dwyer | M | - |
Pricewaterhouse LLP
| - |
James A. Tuell | M | 64 |
Pricewaterhouse LLP
| 13 anni |
Charles Dannewitz | M | 69 |
Pricewaterhouse LLP
| 14 anni |
Fred B. Miller | M | 85 |
Pricewaterhouse LLP
| 33 anni |
George Aylward | M | 59 |
Pricewaterhouse LLP
| 5 anni |
Anthony J. Verkruyse | M | 65 |
Pricewaterhouse LLP
| 11 anni |
John J. Joyce | M | 71 |
Pricewaterhouse LLP
| 3 anni |
J. Breitbach | M | 85 |
Pricewaterhouse LLP
| - |
James Schneider | M | 72 |
Pricewaterhouse LLP
| 10 anni |
Michael D. Matte | M | 65 |
Pricewaterhouse LLP
| 11 anni |
Evan Carpenter | M | - |
Lafayette College
| 4 anni |
David Barr | M | 60 |
Pricewaterhouse LLP
| 4 anni |
Frederick E. Blakelock | M | - |
Lafayette College
| 4 anni |
Bob J. McParland | M | - |
Pricewaterhouse LLP
| 10 anni |
Scott R. Fullerton | M | - |
Lafayette College
| 4 anni |
Alfred Victor Tobia | M | 58 |
Lafayette College
| 4 anni |
William Wagner | M | 57 |
Lafayette College
| 4 anni |
Jack McGlinn | M | - |
Pricewaterhouse LLP
| 4 anni |
Cameron B. Olson | M | 60 |
Pricewaterhouse LLP
| 9 anni |
Barry W. Stewart | M | - |
Pricewaterhouse LLP
| 5 anni |
Jennifer Moyer | F | - |
Pricewaterhouse LLP
| 5 anni |
Ingrid Landråk | F | 54 |
Pricewaterhouse LLP
| - |
Eric Hugel | M | 53 |
Pricewaterhouse LLP
| 4 anni |
Rob Foresti | M | - |
Lafayette College
| 4 anni |
Donald C. Young | M | - |
Lafayette College
| 4 anni |
Seth Kurland | M | - |
Lafayette College
| 4 anni |
David Bradley Herman | M | - |
Lafayette College
| 4 anni |
Chris Pucillo | M | 56 |
Lafayette College
| 4 anni |
Lowell J. Hill | M | - |
Pricewaterhouse LLP
| 4 anni |
Americo Cascella | M | - |
Pricewaterhouse LLP
| 3 anni |
David James Drzadinski | M | - |
Pricewaterhouse LLP
| - |
Andrew M Burdick | M | - |
Lafayette College
| 4 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 98 | 98.00% |
Canada | 2 | 2.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Christopher P. Schnittker
- Contatti personali